Wed. 15 May 2024, 5:01pm ET
Benzinga
Earnings, News
GT Biopharma (NASDAQ:GTBP) reported quarterly losses of $(1.64) per share which beat the analyst consensus estimate of $(2.70) by 39.26 percent. This is a 680.95 percent decrease over losses of $(0.21) per share from the same period last year.